Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study"
J Am Acad Dermatol. 2018 Dec;79(6):e119-e120.
doi: 10.1016/j.jaad.2018.07.052.
Epub 2018 Aug 7.